Tuesday, March 4, 2014

Apheresis Market worth $1.9 Billion - 2017

Apheresis is a process wherein blood is collected and separated into different components, leveraging on centrifugation and membrane separation technology.

MarketsandMarkets recently conducted a study on the “Apheresis Market - Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Procedures (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Devices & Disposables - Forecasts to 2017”, which analyzed and studied the major market drivers, restraints, and opportunities in North America, Europe, Asia, and Rest of the World.
http://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html
Early buyers will receive 10% customization in this report.

The global market is valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017, growing at a CAGR of 11% from 2012 to 2017.

One of the many reasons apheresis is gaining rapid popularity is due to the fact that it is a “subtractive” therapy which seeks to restore the blood in nearly its natural state, thereby preserving the body’s essential functions. Therefore, it can be used to cure intractable diseases as well as in cases where drug administration should be avoided or minimized, as in the case of pregnant women, infants, children, and the elderly.

Free PDF Brochure:

The apheresis industry is oligopolistic in nature with a few large players. The current market leader is Haemonetics Corporation, enjoying one-third of the market share which is shared between its winning apheresis devices like Cymbal, MCS+8150, MCS+9000 and PCS 2 and disposables like Apheresis Solutions, Anticoagulant Citrate Dextrose etc.

A lot is being done to spread awareness and support the cause of smarter blood management systems like apheresis. Haemonetics, the global leader in the apheresis market has announced a research grant along with SABM to support a young researcher planning to study methods of promoting blood conservation.
By technology, the report has classified the apheresis market as centrifugation and membrane separation. Centrifugation technology uses centrifugal force to separate blood components based on their density whereas membrane separation uses the particle size to separate components. The former dominates the market.

Enquiry before Buying:

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com


Post a Comment